Life Sciences
Early results show 70% accuracy of AI-assisted detection of unexplained male infertility using Asian IVF data.
The company helps match patients to relevant clinical trials and engages in recruitment for biopharma partners.
The company recently presented clinical data at the European Society for Medical Oncology Congress for an investigational drug that displayed anti-tumor activity and a good safety profile.
The model also calculates biological ageing and survival patterns to support personalized health risk management.
TrumpRx will offer Novo Nordisk's Ozempic and Wegovy for $350 and Eli Lilly and Company's Zepbound and orforglipron, if approved by the FDA, for $346.
The company says it is seeing an increased demand for testosterone hormone treatment.
Also, a startup from Melbourne has raised $1 million in pre-seed funding for its chemotherapy dosing AI.
The funds will be used to increase the company's development into new automated orthopedic indications and deploy its manufacturing model.
The certifications show that the company meets globally recognized standards for medical imaging.
The company will scale its weight loss offerings ahead of generic GLP-1s coming to the Canadian market in 2026.